Alexza Pharmaceuticals Inc
ALXA
ALXA was delisted on the 16th of June, 2016.
26 hedge funds and large institutions have $3.5M invested in Alexza Pharmaceuticals Inc in 2015 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and 4 closing their positions.
50% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 4
20% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 5
8% more funds holding
Funds holding: 24 → 26 (+2)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
44% less capital invested
Capital invested by funds: $6.21M → $3.5M (-$2.71M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$37.5K |
| 2 |
VKH
Virtu KCG Holdings
New York
|
+$19.4K |
| 3 |
CLOS
Compagnie Lombard Odier SCmA
1204 Geneva,
Switzerland
|
+$18.1K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$11.1K |
| 5 |
JP Morgan Chase
New York
|
+$7.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HHMI
Howard Hughes Medical Institute
Chevy Chase,
Maryland
|
-$122K |
| 2 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$5.41K |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$4K |
| 4 |
Barclays
London,
United Kingdom
|
-$2.58K |
| 5 |
MA
MUFG Americas
New York
|
-$1K |
ALXA Hedge Fund Activity: Q4 2015 in Review
26 of the 3,813 institutional investors tracked by Wall St. Rank reported a position in Alexza Pharmaceuticals Inc (ALXA) for Q4 2015, worth a combined $3.5M — down 44% from $6.21M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new ALXA positions and 4 closed out — a net gain of 2 holders — while 6 added to existing stakes and 5 trimmed.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $37.5K. The largest seller was Howard Hughes Medical Institute, exiting entirely with an estimated $122K sold.
- 26 institutional investors held Alexza Pharmaceuticals Inc (ALXA) as of Q4 2015, up from 24 in Q3 2015.
- Funds reported $3.5M of Alexza Pharmaceuticals Inc stock for Q4 2015, down 44% quarter-over-quarter.
- 6 funds opened new Alexza Pharmaceuticals Inc positions in Q4 2015 and 4 closed out, a net change of +2 holders.
- The largest Alexza Pharmaceuticals Inc buyer in Q4 2015 was Susquehanna International Group, an estimated $37.5K added.
- The largest Alexza Pharmaceuticals Inc seller in Q4 2015 was Howard Hughes Medical Institute, an estimated $122K sold.
Based on aggregated 13F filings for Q4 2015.